Evaluation of Effectiveness of Misoprostol in Office Hysteroscopy : A Prospective Randomized Double Blind Placebo Controlled Trial
Not Applicable
Completed
- Conditions
- Health Condition 1: N858- Other specified noninflammatory disorders of uterus
- Registration Number
- CTRI/2019/04/018458
- Lead Sponsor
- All India Institute of Medical Sciences New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Any premenopausal nulliparous woman undergoing Office Hysteroscopy for any indication as deemed necessary upon clinical evaluation.
Exclusion Criteria
1. Any contraindication for hysteroscopy
i. An ongoing viable pregnancy
ii. Genital tract malignancy
iii. Active per vaginal bleeding
iv. Active genital tract infection
2. Any contraindication for Misoprostol
i. Hypersensitivity to Misoprostol
ii. Uncontrolled severe asthma
iii. Chronic liver or kidney disease
iv. Porphyrias
v. An ongoing viable pregnancy
3. Any contraindication for Clotrimazole
i. Hypersensitivity to Clotrimazole
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method